# A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly

> **NCT00068042** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 100 (—)

## Conditions studied

- Acromegaly

## Interventions

- **DRUG:** Pegvisomant
- **DRUG:** Sandostatin LAR

## Key facts

- **NCT ID:** NCT00068042
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** —
- **Final completion:** 2006-05
- **Target enrollment:** 100 (—)
- **Last updated:** 2008-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00068042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00068042, "A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00068042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*